References
M. Giralt, A. Gavaldà-Navarro, F. Villarroya, Fibroblast growth factor-21, energy balance and obesity. Mol. Cell. Endocrinol. 418(Pt 1), 66–73 (2015)
A. Suomalainen, J.M. Elo, K.H. Pietiläinen, A.H. Hakonen, K. Sevastianova, M. Korpela, P. Isohanni, S.K. Marjavaara, T. Tyni, S. Kiuru-Enari, H. Pihko, N. Darin, K. Õunap, L.A. Kluijtmans, A. Paetau, J. Buzkova, L.A. Bindoff, J. Annunen-Rasila, J. Uusimaa, A. Rissanen, H. Yki-Järvinen, M. Hirano, M. Tulinius, J. Smeitink, H. Tyynismaa, FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10(9), 806–818 (2011)
A. Suomalainen, Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders. Expert. Opin. Med. Diagn. 7(4), 313–317 (2011)
D.R. Crooks, T.G. Natarajan, S.Y. Jeong, C. Chen, S.Y. Park, H. Huang, Elevated FGF21 secretion, PGC-1alpha and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum. Mol. Genet. 23(1), 24–39 (2014)
S. Keipert, M. Ost, K. Johann, F. Imber, M. Jastroch, E.M. van Schothorst, J. Keijer, S. Klaus, Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am. J. Physiol. Endocrinol. Metab. 306(5), E469–E482 (2014)
F. Ribas, J. Villarroya, E. Hondares, M. Giralt, F. Villarroya, FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signaling. Biochem. J. 463(2), 191–199 (2014)
Y. Jeanson, F. Ribas, A. Galinier, E. Arnaud, M. Ducos, M. André, V. Chenouard, F. Villarroya, L. Casteilla, A. Carrière, Lactate induces FGF21 expression in adipocytes through a p38-MAPK pathway. Biochem. J. 473(6), 685–692 (2016)
C.H. Zhu, V. Mouly, R.N. Cooper, K. Mamchaoui, A. Bigot, J.W. Shay, J.P. Di Santo, G.S. Butler-Browne, W.E. Wright, Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6(4), 515–523 (2007)
J.E. Manning Fox, D. Meredith, A.P. Halestrap, Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J. Physiol. 529(Pt 2), 285–293 (2000)
S. Parikh, A. Goldstein, M.K. Koenig, F. Scaglia, G.M. Enns, R. Saneto, I. Anselm, B.H. Cohen, M.J. Falk, C. Greene, A.L. Gropman, R. Haas, M. Hirano, P. Morgan, K. Sims, M. Tarnopolsky, J.L. Van Hove, L. Wolfe, S. DiMauro, Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet. Med. 17(9), 689–701 (2015)
A. Morovat, G. Weerasinghe, V. Nesbitt, M. Hofer, T. Agnew, G. Quaghebeur, K. Sergeant, C. Fratter, N. Guha, M. Mirzazadeh, J. Poulton, Use of FGF-21 as a biomarker of mitochondrial disease in clinical practice. J. Clin. Med. 6(8), E80 (2017)
R. Montero, D. Yubero, J. Villarroya, D. Henares, C. Jou, M.A. Rodríguez, F. Ramos, A. Nascimento, Cl Ortez, J. Campistol, B. Perez-Dueñas, M. O’Callaghan, M. Pineda, A. Garcia-Cazorla, J.C. Oferil, J. Montoya, E. Ruiz-Pesini, S. Emperador, M. Meznaric, L. Campderros, S.G. Kalko, F. Villarroya, R. Artuch, C. Jimenez-Mallebrera, GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction. PLoS ONE 11(2), e0148709 (2016)
M. Ost, V. Coleman, J. Kasch, S. Klaus, Regulation of myokine expression: Role of exercise and cellular stress. Free Radic. Biol. Med. 98, 78–89 (2016)
E. Blohm, J. Lai, M. Neavyn, Drug-induced hyperlactatemia. Clin. Toxicol. (Phila.). 55(8), 869–878 (2017)
P. Domingo, J.M. Gallego-Escuredo, J.C. Domingo, MdelM. Gutiérrez, M.G. Mateo, I. Fernández, F. Vidal, M. Giralt, F. Villarroya, Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients. AIDS 24(17), 2629–2637 (2010)
Acknowledgements
This study has been supported by Ministerio de Economía y Competitividad Spain (Grant SAF2017-85722-R to FV) and Instituto de Salud Carlos III, Spain (Grant PI17/00420 to M.G.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Villarroya, J., Campderros, L., Ribas-Aulinas, F. et al. Lactate induces expression and secretion of fibroblast growth factor-21 by muscle cells. Endocrine 61, 165–168 (2018). https://doi.org/10.1007/s12020-018-1612-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-018-1612-6